Is a Pre-contrast Scan Necesary to Diagnose Acute Aortic Syndrome?
NCT ID: NCT02273245
Last Updated: 2015-11-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
160 participants
OBSERVATIONAL
2015-01-31
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Current practice is to image this with two CT scans of the chest, one before injection of a contrast dye into the blood stream and then one after.
With the advancement of CT scanner technology, improvements in software interpretation and screen resolution, the investigators hypothesise that performing the contrast scan on its own is diagnostically equivalent to both the pre- and contrast scans
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Predictors of Aortic Aneurysm Growth and Rupture
NCT02022436
Transthoracic Ultrasound Evaluation of Thoracic Aortic Aneurysms
NCT05137366
Prevalence of Abdominal Aortic Aneurysm in Patients Undergoing Coronary Angiography
NCT01239225
Screening Cardiovascular Patients for Aortic Aneurysms
NCT01643317
Aortic Elongation and Dissection
NCT02722889
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Current practice is to image this with two CT scans of the chest, one before injection of a contrast dye into the blood stream and then one after. The one before the contrast is used to determine if there is bleeding within the wall, which would show up as white on this scan. It is currently accepted that the contrast in the artery itself would hide the presence of bleeding within the wall. The other causes are seen primarily on the contrast scan only. Every patient proceeds from the pre-contrast scan to the contrast scan, unless there is a contraindication to the intravenous dye.
The investigators own database search has shown that radiologists protocol the scans according to their own preference and experience (i.e. some do both scans, others the contrast scan only). There is conflicting advice from international professional bodies as to whether to perform the non-contrast scan every time.
Some studies have shown that although the pre-contrast scan is sensitive to picking up bleeding within the wall, it adds nothing more over an increased radiation dose to the patient.
The investigators hypothesise that performing the contrast scan on its own is diagnostically equivalent to both the pre- and contrast scans to look for all 4 of these entities that make up AAS. The investigators also propose that not requiring the pre-contrast scan would have significant savings in patient radiation dose, scanner time, network resources and radiologist time.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
thoracic aortgram CTs
A retrospective cohort assessment of thoracic aortogram CTs of male and female adult (age\>18) patients presenting with symptoms of AAS.
Thoracic aortogram CT
With and without contrast dye
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thoracic aortogram CT
With and without contrast dye
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Plymouth NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carl Roobottom, MBChB FRCP
Role: STUDY_DIRECTOR
Plymouth Hospital NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Plymouth Hospitals NHS Trust
Plymouth, Devon, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14/P/155
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.